Participant flow

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Includes patients that were treated with deferasirox for 6 months.

   id

   FG000

   title

   Deferasirox Treated

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         3

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         3

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

4 patients were consented, however, one withdrew consent before receiving treatment.

recruitment Details

Only one site (Masonic Cancer Center) enrolled patients in this study.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice